Registration rules, dossier documents, timelines, fees, and local representative requirements for interventional devices entering the Dominican market — answered in one place.
October 1, 2026
12
min read
By
BioAccess Editorial Team
Dominican Republic
DIGEMAPS
medical device registration
market access
Latin America
interventional devices
registro sanitario
**Key takeaways**
- • Yes — registration is mandatory. All medical devices, including non-implantable interventional devices, need a DIGEMAPS registro sanitario before import and sale.
- • No direct foreign registration. The registro must be held by a Dominican-domiciled, DIGEMAPS-licensed titular (local representative).
- • Plan for 6–12 months in practice for a first registration, with a 5-year validity and affirmative renewal.
- • Government fees are modest (roughly USD 200–600); the real cost is the dossier, translations, and local representation.
- • Enforcement is now electronic. VUCE routes import permits through DIGEMAPS — unregistered devices face customs holds.
**Who is this for?**
This guide is for regulatory affairs directors, market access managers, and MedTech executives planning to commercialize interventional medical devices — catheters, guidewires, sheaths, stents, and related products — in the Dominican Republic.
The short answer
Yes. Non-implantable interventional medical devices require a registro sanitario (sanitary registration) from DIGEMAPS — the Dirección General de Medicamentos, Alimentos y Productos Sanitarios — before importation and sale in the Dominican Republic. There is no notification-only or exemption route for Class II–IV devices; "non-implantable" does not exempt a device from registration. The registro must be held by a Dominican-domiciled, DIGEMAPS-licensed local representative (titular), and customs (DGA) now checks registration electronically through the VUCE single-window system — so shipping first and registering later is not a workable strategy. For manufacturers who want a turnkey path, see bioaccess®'s Dominican Republic market access page.
What is DIGEMAPS and what law requires registration?
DIGEMAPS is the Dominican Republic's health-products regulator, operating under the Ministerio de Salud Pública (Ministry of Public Health). It was created by Decreto 82-15 as the authority responsible for the sanitary registration of medicines, foods, and productos sanitarios (health products, including medical devices). The legal framework rests on:
- Ley General de Salud 42-01 — the health framework law covering medicamentos y productos sanitarios
- Decreto 246-06 — the medicines regulation, applied by extension to health products
- Decreto 82-15 — creates DIGEMAPS within the Ministry of Public Health
- Decreto 1138-03 — governs the licensing (habilitación) of health establishments, including importers and distributors
- DIGEMAPS resolutions on medical devices from 2016 onward — including the device classification and registration procedures (Resoluciones 000004-2016 and 000021-2017)
Under this framework, commercial medical devices may not be imported or marketed without a valid registro sanitario. The registration is product-specific and is issued in the name of the local titular (holder).
Do non-implantable interventional devices really need registration?
Yes — with high confidence. The registration obligation applies to medical devices as a category, not by implantability. Interventional devices such as diagnostic and guiding catheters, guidewires, introducer sheaths, angioplasty balloons, and stents all require registration before import and sale, regardless of whether they remain implanted in the patient.
A persistent industry myth holds that device registration in the Dominican Republic is not really enforced — a belief rooted in the pre-2016 era, when many devices entered on importer licensing alone. That era is over (see the enforcement section below). The only carve-outs from the commercial registration requirement are narrow:
- Donations of medical devices (case-specific permit)
- Devices imported for an approved clinical investigation
- Single-patient or institutional emergency use
- Devices in a formal regulatory transition period
**No 'ship first, register later' strategy**
DIGEMAPS will not issue an import authorization for an unregistered device, and customs (DGA) will not release it. Budget registration into your launch timeline from day one.
How are interventional devices classified in the Dominican Republic?
DIGEMAPS classifies medical devices into four risk classes — I, II, III, and IV — following the GHTF/IMDRF risk model. Classification depends on the device's intended use, degree of invasiveness, duration of body contact, and whether it contacts the central circulatory system (CCS) or central nervous system (CNS) — not simply on whether the device is implantable.
| Class | Risk level | Typical interventional examples |
|---|---|---|
| Class I | Low | Non-invasive accessories, manual surgical instruments |
| Class II | Low–moderate | Peripheral diagnostic catheters, guidewires, introducer sheaths |
| Class III | Moderate–high | Coronary and cardiac catheters, neurovascular devices, angioplasty balloons |
| Class IV | High | Drug-coated devices, long-term implants, devices incorporating medicinal substances |
Most non-implantable interventional devices fall in Class II or Class III. Class I devices follow a lighter notification/registration route; Classes II–IV require full registration. Getting the classification right at the start matters — it determines the dossier depth, review intensity, and whether clinical evidence summaries are expected.
Can a foreign manufacturer register directly with DIGEMAPS?
No. The registro sanitario is issued in the name of a titular — a Dominican-domiciled legal entity licensed by DIGEMAPS. A foreign manufacturer cannot hold the registration in its own name. The manufacturer appoints the titular through a Poder de Representación (power of attorney) or Carta de Autorización/Representación issued by the legal manufacturer (not a distributor), which must:
- Identify the manufacturer, the Dominican representative, and the device(s) or families covered
- Expressly authorize the local entity to apply for, hold, maintain, and renew the registro and act before DIGEMAPS/MSP
- Be notarized in the country of origin and apostilled — the DR has been a Hague Apostille Convention party since 2009
- Be translated into Spanish by a Dominican intérprete judicial (sworn translator)
The local holder/importer must itself hold the following licenses:
| Requirement | Issued by | Notes |
|---|---|---|
| RNC and incorporation documents | DGII / Cámara de Comercio | Standard legal-entity requirements |
| Registro de Importador | DGA (customs) | Needed to clear goods and operate in VUCE |
| Habilitación / Licencia de Establecimiento as importer-distributor of health products | MSP with DIGEMAPS | Requires premises inspection, a designated responsable técnico (typically a pharmacist), and SOPs |
| Good storage and distribution practices compliance | DIGEMAPS inspection | Verified during habilitación; no separate GMP certificate is required of the importer itself |
| VUCE user registration | DGA / VUCE platform | To request DIGEMAPS import authorizations electronically |
**Titular choice is a commercial decision, not just a regulatory one**
Changing the titular later is a formal post-approval variation requiring a new power of attorney and manufacturer consent — a frequent commercial friction point when the distributor holds the registration. Our recommendation for the Dominican Republic: appoint your Dominican distributor as the titular (holder) and importer of record, engage a third-party regulatory provider like bioaccess® to prepare and prosecute the DIGEMAPS filing, and build registration-transfer clauses into your distribution agreement — reviewed by Dominican counsel to ensure they are locally enforceable — so the registro can be transferred to a replacement distributor if the first one fails to meet expectations. (Argentina is the exception: it is a large enough market that bioaccess® provides full titleholder and importation services there directly.)
What documents does the DIGEMAPS dossier require?
For a Class II or III non-implantable interventional device (catheters, guidewires), the expediente de registro sanitario typically contains:
Administrative documents
- DIGEMAPS application form (formulario de solicitud de registro sanitario de dispositivos médicos), signed by the titular and the responsable técnico
- Power of attorney / letter of authorization from the legal manufacturer — notarized, apostilled, translated
- Copy of the titular's establishment license (habilitación) and RNC
- Certificate of Free Sale (Certificado de Libre Venta) from the competent authority of the country of origin or a reference market where the device is marketed (FDA Certificate to Foreign Government, EU CFS, Health Canada) — must list the device models, be current (issued within 1–2 years), apostilled, and translated
- ISO 13485 certificate of the legal manufacturer (and critical contract manufacturer or sterilizer, if different) from an accredited body — notarized/apostilled copy plus translation
- Evidence of origin-market authorization: FDA 510(k) clearance letter or PMA approval, EC certificate plus Declaration of Conformity
- Proof of payment of government fees
Technical documents
- Device description, intended use, indications and contraindications, catalog numbers, and variants/sizes (families grouped by same intended use, technology, and manufacturer)
- Classification rationale by risk class
- Materials and components; biocompatibility summary (ISO 10993)
- Manufacturing process summary; sterilization method and validation summary (ISO 11135/11137); packaging and shelf-life justification
- Risk management summary (ISO 14971); safety and performance checklist
- Performance testing summary; clinical evaluation summary (clinical evidence expected for Class III/IV)
- Labeling and Instructions for Use in Spanish — DIGEMAPS generally accepts multilingual original labeling plus a Spanish IFU, and permits an etiqueta complementaria (Spanish stick-on label with titular name, registro number, and importer) applied before distribution
- Samples or photographs of the device and packaging (samples may be requested for some classes)
**Apostille and translation rule of thumb**
Every public or notarized foreign document — CFS, POA, notarized ISO/CE/FDA copies, manufacturer declarations — must be apostilled (or consular-legalized if the issuing country is not a Hague party) and translated by a Dominican intérprete judicial. Purely technical documents (test reports, validation summaries, risk management) do not need apostille but must be in Spanish or accompanied by a Spanish translation. China is a Hague Apostille Convention party (since 2023), so Chinese-issued documents can be apostilled rather than consular-legalized.
How long does DIGEMAPS registration take?
DIGEMAPS's published service standards cite roughly 60–90 business days of review for a complete filing. In practice, first registrations commonly take 6–12 months, and 12–18 months is not unusual when deficiency letters (observaciones) are issued — which stop the clock and must be answered within a fixed period (typically 30 business days, extendable once) or the file is archived.
| Phase | Typical duration | Key activities |
|---|---|---|
| Dossier preparation | 2–4 months | Document collection, apostille, sworn translations, gap analysis |
| Submission and admissibility | 2–4 weeks | DIGEMAPS completeness check; observaciones possible |
| Technical review | 4–9 months | Reviewer evaluation, query cycles, sample requests |
| Resolution and issuance | 4–8 weeks | Resolución de registro, registro number assignment |
| Total (first registration) | 6–12 months | 12–18 months when multiple observaciones rounds occur |
Renewals and variations are usually faster — roughly 3–6 months — when filed before expiry; filing before expiry keeps the registro in force while the renewal is pending. bioaccess® confirms the expected timeline at the proposal stage based on the device's class and dossier readiness.
What does DIGEMAPS registration cost?
DIGEMAPS government fees are modest relative to other Latin American regulators and are set by the MSP tarifario rather than tiered steeply by class. Publicly cited amounts for device registrations are in the low tens of thousands of Dominican pesos per registro (roughly USD 200–600), with separate, smaller fees for renewals, variations (modificaciones), and certified copies. Because the tarifario is updated by resolution, confirm the current schedule at the proposal stage — local agent fees typically exceed government fees by a wide margin.
The real budget drivers are dossier preparation, apostille and sworn translations, samples, and the regulatory filing itself. Government fees are modest (typically a few hundred USD); the commercial cost is the in-country work. bioaccess® provides the DIGEMAPS registration processing as a quoted service — dossier preparation, sworn translations, agency liaison, and tecnovigilancia — while your distributor holds the registro. See the Dominican Republic market access page for current commercial terms.
The registro sanitario is valid for 5 years from the date of the registration resolution. Renewal is an affirmative filing obligation: apply 3–6 months before expiry with an updated Certificate of Free Sale, a valid ISO 13485 certificate, current labeling, and a declaration of no changes (or a listing of changes already approved as variations).
Is there a fast track for FDA-cleared or CE-marked devices?
DIGEMAPS does not operate a formal fast-track or reliance program comparable to some other Latin American regulators — but its review is reliance-based in substance. Registration of an imported device is conditioned on a Certificate of Free Sale plus a QMS certificate (ISO 13485) and the origin-market authorization (FDA clearance/approval, CE certificate, or authorization from another recognized regulator). DIGEMAPS does not independently re-review design verification — the technical dossier receives a summary review.
- A CFS from FDA or an EU authority carries the most weight in practice
- PAHO reference authorities (ANVISA, ANMAT, COFEPRIS, INVIMA, CECMED, ISP Chile) are generally accepted as CFS sources
- Class I devices follow a lighter notification/registration route; Class II–IV require full registration
- The device classification and registration procedures issued in 2016–2017 (Resoluciones 000004-2016 and 000021-2017) establish the risk-based classification and the documentary basis for accepting reference-authority certificates
Practical implication: manufacturers with FDA 510(k) clearance or CE marking already hold the two most valuable documents in the file — the CFS and the origin-market authorization. The remaining work is local: the titular, the apostilled POA, sworn translations, and Spanish labeling.
What happens if you import without registration?
Two eras, one answer. Historically (pre-2016 through roughly 2019), device registration was poorly enforced in the Dominican Republic — many devices entered on importer licensing alone, and registering the trademark with ONAPI was common commercial practice (for brand protection and against parallel imports) but was never a legal sanitary requirement for import. That history is the source of the "registration isn't really enforced" myth.
Today, DIGEMAPS is integrated into VUCE (Ventanilla Única de Comercio Exterior), the foreign-trade single window, and customs (DGA) routes designated tariff lines — HS Chapter 90 instruments, 30.05/30.06 medical consumables, and others — for a DIGEMAPS import authorization (Autorización / No Objeción de Importación). The registro sanitario (or an exemption permit) is checked electronically before release. Unregistered devices now face holds at customs.
- Import permits are tied to the registro — no registration, no import authorization
- Public procurement (PROMESE/CAL, SNS hospitals) and large private networks increasingly require a valid registro sanitario in tenders — now the strongest commercial driver
- Enforcement intensity varies by HS code and how it is flagged in VUCE, but relying on gaps is not a compliance strategy
- Devices imported for a clinical investigation enter under a study-specific DIGEMAPS import permit (tied to ethics and MSP authorization), not under a commercial registro
Frequently Asked Questions
Sources and basis of this article
This article is based on the Dominican regulatory framework as of October 2026: Ley General de Salud 42-01; Decreto 246-06; Decreto 82-15 (official DIGEMAPS text); Decreto 1138-03; DIGEMAPS device classification and registration resolutions (2016–2017); and regulatory analysis with Mike Legal AI (decision support, not a licensed attorney). Fees, timelines, and resolution-level details change by DIGEMAPS notice — confirm the current tarifario and requirements with the local titular or DIGEMAPS directly before budgeting. This article is general information, not legal advice.
BA
bioaccess® · End-to-end medical device registration and market access services across Latin America and the Caribbean, including DIGEMAPS (Dominican Republic), COFEPRIS (Mexico), ANVISA (Brazil), INVIMA (Colombia), and ANMAT (Argentina).
Market Access Services
Dominican Republic Overview
Ready to register your device with DIGEMAPS?
The Dominican Republic is a growing Caribbean device market — but entry runs through DIGEMAPS registration, a licensed local titular, and an apostilled dossier. bioaccess® prepares and prosecutes your DIGEMAPS filing as your third-party regulatory provider — dossier, sworn translations, agency liaison, and tecnovigilancia — while your Dominican distributor holds the registro as titular and importer of record, with transfer clauses in your distribution agreement protecting you if the commercial relationship changes.
Schedule a Strategy Call
Dominican Republic Market Access
Related resources:
- Dominican Republic Market Access — /market-access/dominican-republic-digemaps
- Market Access Services — /market-access
- COFEPRIS medical device registration in Mexico — /blog/cofepris-medical-device-registration-mexico
- Clinical trial insurance in Latin America — /blog/clinical-trial-insurance-latin-america